OCDX Ortho Clinical Diagnostics Holdings plc

Ortho Clinical Diagnostics Holdings plc engages in the vitro diagnostics business in the United States. The company offers automated instruments; and assays, reagents, and other consumables that are used by these instruments to generate test results. Its solutions include clinical chemistry and immunoassay instruments and tests to detect and monitor disease progression across a broad spectrum of therapeutic areas, including COVID-19 antibody and antigen tests; and immunohematology instruments and tests for blood typing to ensure patient-donor compatibility in blood transfusions, as well as donor screening instruments and tests for blood and plasma screening for infectious diseases. The company also engages in contract manufacturing activities; and provides ortho-care services. Its products are used in hospitals and laboratories; and physician offices, clinics, blood banks, donor centers, and other specialty settings. The company was founded in 1939 and is headquartered in Raritan, New Jersey.

$21.12  +0.37 (1.78%)
As of 05/13/2021 11:55:47 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  United Kingdom
IPO date:  01/28/2021
Outstanding shares:  234,742,792
Average volume:  883,565
Market cap:   $4,969,504,907
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G6829J107
ISIN:        GB00BMDNH979
Sedol:      BMDNH97
Valuation   (See tab for details)
PE ratio:   -63.69
PB ratio:   13.26
PS ratio:   2.45
Return on equity:   -65.99%
Net income %:   -9.05%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy